Pharmaguy's Insights Into Drug Industry News
185.9K views | +2 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Viagra DTC TV Ad Spending Deflates Like Tom Brady’s Balls

Viagra DTC TV Ad Spending Deflates Like Tom Brady’s Balls | Pharmaguy's Insights Into Drug Industry News | Scoop.it

TV networks are trying to keep a stiff upper lip as the once-lucrative erectile dysfunction sector has begun sagging like a doctored football in Tom Brady's throwing hand. According to multiple insiders, a certain little blue pill has all but vanished from the airwaves, and its absence will be particularly conspicuous during the upcoming NFL season.

 

Nearly 20 years after the FDA first approved its use as an ED remedy, Pfizer's Viagra is losing its patent exclusivity, and that's a bitter pill to swallow for the TV business. Viagra hasn't aired a national TV advertisement since May 15, and network ad sales executives said the brand is unlikely to resurface, having sat out the 2017-18 upfront bazaar.

 

Football fans should notice the dearth of Viagra spots as early as Sept. 7, when NBC is set to broadcast its annual NFL Kickoff Game. When the Chiefs and Patriots square off in Foxborough, their clash will not be interrupted by pitches for what was until recently the NFL's top-spending pharmaceutical brand; according to iSpot.tv data, Viagra last season invested nearly $31 million in pro football inventory.

 

Ad sales bosses say that the disappearance of one of the NFL's top 40 highest-spending advertisers is a function of Viagra losing its exclusivity in the face of the impending launch of a generic version of the brand. Teva Pharmaceuticals is set to roll out a far cheaper variant of the compound on Dec. 11.

 

"Once a generic gets in the mix, that usually spells the end of any direct-to-consumer advertising for the legacy brand," said one ad sales exec. "Rather than continue to market something they no longer have exclusivity over -- which really can only help boost sales of the new generic pill -- the pharmaceutical company will reallocate that portion of its budget back into its brands that are still exclusive."

 

Further Reading:

  • A Dick Move by Pfizer: Raises Price of Viagra & Other Drugs by as Much as 28% in One Year!: http://sco.lt/5VHAjh 
  • Will You Miss Those ED DTC TV Ads When Viagra & Cialis Go Generic? John LaMattina Will: http://sco.lt/5bsTdh 
more...
Scooped by Pharma Guy
Scoop.it!

Pfizer’s Latest Viagra TV Ad Pitches Discounts vai Mobile Texting

Pfizer’s Latest Viagra TV Ad Pitches Discounts vai Mobile Texting | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The same way they do to vote for a favorite singer on “The Voice,” consumers can now text Pfizer for a discount on erectile dysfunction drug Viagra. In what seems to be a first for a pharma company, Pfizer’s new TV commercial for Viagra encourages patients to text a keyword from their mobile phones to receive special discounts.

In typical Viagra direct-marketing style, it’s not a soft-sell message tacked on at the end of the ad. The ad opens with the now-familiar woman in a dark blue dress who asks, “Guys, want to save 50% on a yearlong supply of Viagra for ED?” A mobile phone close-up then takes over the screen with the promotion and text keyword “VSAVE,” and she explains in voice-over how to get the discount. 

Pfizer declined to comment on the promotion, with a spokesman citing, via email, “a policy against sharing competitive information.”

more...
No comment yet.
Suggested by CoffeeTableScience
Scoop.it!

The Story of Viagra: How Pfizer Sold the Right Drug to the Wrong People!

The Story of Viagra: How Pfizer Sold the Right Drug to the Wrong People! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

In 1989, researchers Peter Dunn and Albert Wood, working at the Pfizer’s research facility at Kent, England, were able to synthesize a drug that could be used to treat patients with high blood pressure and chest pain. Called Sildenafil citrate, this drug could inhibit functioning of the enzyme, cGMP-specific phosphodiestrase type 5, simply called PDE-5, making blood vessels more receptive to nitric oxide in the blood, further leading to the relaxation of the arterial wall and regulation of blood pressure. Like every other drug discovery, Sildenafil citrate, too, now had to go through rigorous clinical trials before being able to actually help patients. Phase I clinical trials were conducted at a hospital in Wales which did not progress very well. In addition to the regular side-effects such as headache, impaired vision and indigestion, sildenafil was also found to result in unintended penile erections in male subjects. What was even worse for Pfizer is that the study found that the drug did not make a significant contribution to treating angina in patients. Phase II trials were also conducted for the drug, but data from the study could not show a correlation between administration of sildenafil and improvement in cases of angina. However, instead of stopping the project altogether, the company invested time and effort in recognizing the cause for these side effects.

 

Investigations by Pfizer lead them to the fact that PDE-5 is largely located in the arterial wall of the lungs and smooth muscles of the male penis. In addition to acting on the arterial walls, Sildenafil also found its way to these smooth muscles and acted exactly the way it was expected to behave. Pfizer realised that the erection seen in patients was no side-effect at all and they had stumbled upon a major discovery in the field of reproductive medicine. After a few more years of research, a patent application in the year 1996 and approval of US FDA in 1998, Pfizer presented the world with a diamond shaped, blue pill, commonly known as Viagra.

 

Although Viagra was introduced as a prescription drug, Pfizer made every effort to market it to every household they could, not only in the United States but also worldwide.

The marketing of the drug was done so well that within a couple of years of its release, Viagra accounted for 92% of the global prescriptions for erectile dysfunction and even though its market share has dropped is helping Pfizer make millions every year.

 

While the drug shows remarkable improvement in people affected by erectile dysfunction, there is hardly any evidence to show that it works for healthy individuals. Originally Viagra was available only by prescription, but since several other brands are now available in the market, sildenafil citrate can be bought anonymously over the internet or also as an over-the-counter drug, leading to the use of this drug by normal healthy individual as an aphrodisiac. This un-prescribed and unsupervised usage of the drug, borders on the lines of addiction and drug abuse. Apart from recreational purposes, this drug can also be used in recovery from jet lags, increasing athletic performance and also extending shelf life of cut flowers, strawberries, broccoli and other perishables. Ideas for home science, anyone?

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

No Note from Your Wife? No Viagra for You, Says Kentucky Lawmaker

No Note from Your Wife? No Viagra for You, Says Kentucky Lawmaker | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Tired of what she considers the government inserting itself into women’s private lives, a Kentucky lawmaker has decided to return the favor.


Rep. Mary Lou Marzian, a Louisville Democrat, has introduced a bill that would force men who want to use erectile dysfunction drugs to jump through a series of humiliating hoops beforehand, such as visiting a doctor twice and getting notes from their wives.


“I want to protect these men from themselves,” Marzian, who is a nurse, told the Courier-Journal.


“This is about family values,” she added.


Mazian told Fox affiliate WDRB that House Bill 396 would also require that someone seeking Viagra, Cialis, Levitra or Avanafil “make a sworn statement with his hand on a Bible that he will only use a prescription for a drug for erectile dysfunction when having sexual relations with his current spouse.”


“I started thinking, ‘How would this body of men feel if the government was injecting [itself] into their private medical decisions,’ ” she added.


Marzian’s proposal arrives a week after Kentucky Gov. Matt Bevin (R) signed a bill requiring women to consult with a doctor at least 24 hours before an abortion, according to the Courier-Journal. The “informed consent” bill, as it was labeled, passed with 92 “yes” votes on Jan. 28, according to WDRB.  Marzian was one of three members of the Kentucky House to vote against the law, the station noted.

Pharma Guy's insight:

You might also be interested in this: 'FDA Wants to Peek Into Your Bedroom to Learn If Your Spouse Affects Your Perception of Risks in Those New Viagra TV Ads!"; http://sco.lt/7Lsw4n 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Pfizer Regrets Viagra's Pharmacy Payola Scheme Violated Chinese Law

Pfizer Regrets Viagra's Pharmacy Payola Scheme Violated Chinese Law | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Pfizer  has been fined 100,000 yuan($15,570) by Shanghai's market supervision authorities for paying four drugstore chains torecommend its market-leading erectile dysfunction drug, Viagra. 


Pfizer signed two agreements with China National Medicines Corporation Ltd in 2004 toexclusively distribute and sell Viagra, according to a statement by authorities. 


Between 2011 and 2013, Pfizer had signed agreements with the four drugstore chains tohave them display the drug in Shanghai to boost sales. 


The agreements required the stores to display Viagra as a recommended product, and ensurethe product was given what the authorities called a centralized, fixed position on prescription-drugs counters, with a certain quantity of display and specific space. 


Shanghai's Pudong market supervision and management department said Pfizer paid nearly930,000 yuan for such displays which they said violated drug management rules. 


Officials said the rules prohibit drug manufacturing and operating companies and medicalbodies during the buying and selling of drugs of giving or receiving kickbacks or otherbenefits, in what it called under-the-counter deals. 


The authorities have asked Pfizer to correct the illegal behavior, and confiscated allegedincome of nearly 2.96 million yuan, as well as imposing the 100,000 yuan fine. 


Pfizer said it had accepted the administration penalty decision made by the Pudongauthorities. 


"Due to some lapses in supervision, the display agreements were not executed accurately inthese pharmacies," Pfizer said in a written reply to China Daily. 


"Once this matter was brought to the attention of Pfizer's leadership in China, we tookimmediate action to investigate the matter and cooperated fully with Chinese authorities. 


"We deeply regret that certain conduct may have violated Pfizer's policies and the laws inChina. Pfizer regularly reviews our processes and we have already incorporatedimprovements in our policies and practices related to pharmacies, to ensure that we complywith all laws that apply to our business activities in China and throughout the world," said thecompany. 

Pfizer has a dominant share of the Chinese erectile dysfunction medicine market with itspatented Viagra.

Pharma Guy's insight:

Meanwhile, in Japan hand-held fans like the ones shown here -- emblazoned with Viagra commercial messages and logos -- are popular when it gets hot. 


According to  RocketNews24, "while many applauded the creativeness of these fans, many net users wrote it off as 'gay' or 'just for fujoshi.'" According to wikipedia, fujoshi is a self-mockingly pejorative Japanese term for female fans of novels that feature romantic relationships between men.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

His and Hers Hand Towels Monographed with Viagra and Addyi Logos. Only $20!

His and Hers Hand Towels Monographed with Viagra and Addyi Logos. Only $20! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

$20.00 USD

Overview

  • Handmade item
  • Materials: terry cloth, sildenafil citrate, flibanserin, microcrystalline cellulose, etc.
  • Only ships to United States





Feedback

Looks great in my waiting room bathroom. I have had many compliments and requests for samples of the pills! – Dr. FeelGood, Bethesda, MD


More...

Pharma Guy's insight:

The co-marketing possibilities are endless!

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Only 10% of Americans Would Pay Attention to Sexy Online Ads

Only 10% of Americans Would Pay Attention to Sexy Online Ads | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The first annual Goo Online Advertising Survey of over 2,000 Americans aged 18 and older, conducted online by Harris Interactive on behalf of Goo Technologies is alarming. The survey reveal consumer behavior around the types of ads we see every day, found that fully 92% of Americans ignore at least one type of ad, including:


Ten percent of Americans even said they were more likely to pay attention to an online ad if it featured a sexy man or woman.

Pharma Guy's insight:


That sounds odd. Pfizer must disagree - it's new Viagra ad is almost as sexy as Victoria Secret ads (see Oh Yeah, Baby! Show Me More!... Viagra TV Ads Like This. But Don't Let My FDA See It!). Although I've seen the sexy woman Viagra banner ads on the Internet, he most impactful ad is the video ad shown on TV when OLDER American mend are likely to be watching. I bet much more than 10% of that demographic is likely to pay attention to sexy ads online or off!


What about physicians? The pharma industry was very successful selling their products to physicians and sexy female (and male) sales reps were key. See, for example, Sexy Reps Sell Rx Drugs


more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Marvin Tells It Like it Is!

Marvin Tells It Like it Is! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

I hope I don't get into trouble for modify this Marvin comic strip (find the original here). For background, read "Oh Yeah, Baby! Show Me More!... Viagra TV Ads Like This. But Don't Let My FDA See It!"

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

"Plenty" of Guys Have Erectile Dysfunction Says Middle-Aged Woman in Viagra TV Ad

"Plenty" of Guys Have Erectile Dysfunction Says Middle-Aged Woman in Viagra TV Ad | Pharmaguy's Insights Into Drug Industry News | Scoop.it

In the new 60-second ad, a middle-aged woman reclining on a bed in a tropical setting addresses the problems couples encounter when a man is impotent.


"So guys, it's just you and your honey. The setting is perfect. But then erectile dysfunction happens again," she says before encouraging men to ask their doctor about Viagra. "Plenty of guys have this issue — not just getting an erection, but keeping it."


Having a woman speak directly to men about impotence is a unique strategy for Pfizer Inc. The world's second-biggest drugmaker is looking for ways to boost sales of Viagra, Pfizer's No. 6 seller, at a time when it is encountering new competition.


Executives at New York-based Pfizer hope the new ad campaign, which includes print ads in publications such as Esquire and Time, will nudge women to broach the subject with their mates. In the ad, the actress also uses the word "erection," instead of the industry euphemism, "ED."


Pfizer's marketing chief, Vic Clavelli, told The Associated Press that the company is trying to take a more direct approach in ads, unlike past ones "built around very subtle innuendo."


Until now, women have been absent or played background roles in the many ads for ED drugs since the first, Viagra, was launched in 1998. 

Pharma Guy's insight:


Ewww! That's the last thing a man wants to hear from a woman! Perhaps a middle-aged woman is OK, but, you know 40 is the new 25 these days.


I'll hold off my criticism until I see the ad. 


BTW, last night's HBO series "Masters of Sex" was all about treating ED through a non-sexual regimen that involves touching, etc. The Cialis commercials "touch" on that. Who knows, it may be why Cialis is competing well with Viagra!

more...
vacurect's comment, June 13, 2017 12:56 AM
Vacurect ED pump for Erectile Dysfunction problem or you want to natural erection. its 100% safe and US FDA Certified. Vacurect is OTC Device and its also safe for BP & Diabetics. Visit : www.vacurect-india.com
Scooped by Pharma Guy
Scoop.it!

Will You Miss Those ED DTC TV Ads When Viagra & Cialis Go Generic? John LaMattina Will

Will You Miss Those ED DTC TV Ads When Viagra & Cialis Go Generic? John LaMattina Will | Pharmaguy's Insights Into Drug Industry News | Scoop.it

[LaMattina, a former Pfizer Executive says...] Proprietary drugs have a limited patent life, and each year dozens of big drugs lose patent protection. As a result, generic competition kicks in for these drugs, their prices drop precipitously and the originating companies lose billions of dollars in revenues. But, that’s the nature of this business.

 

Eric Sagonowsky of FiercePharma recently published an article outlining the top 10 patent losses for 2017. Leading his list is Copaxone, an MS drug with $3.48 billion in sales last year. But right behind Copaxone on the list are two very familiar drugs, Lilly’s Cialis and Pfizer’s Viagra, both billion-dollar sellers in the U.S. Sagonowsky goes on to talk about the impact of generic competition on each company’s bottom line, which will be very substantial.

 

But he fails to note the resulting societal impact that the loss of exclusivity for these erectile dysfunction (ED) drugs will have. Once generic competition occurs for a brand name drug, companies generally will stop direct-to-consumer advertising (DTC) for its medication. Why promote a brand name drug in the face of generics? You would just help drive sales of the cheaper generic forms. A company’s DTC budget is better spent on drugs that still have exclusivity.

 

However, the impact on society for the loss of erectile dysfunction TV ads is unappreciated. No longer will fathers have the educational opportunity to answer the inevitable question by their 10-year-old daughters that arises during Sunday NFL games: “Daddy, what’s erectile dysfunction?” The subtle reminders of the importance of good hygiene, now promoted by the Cialis commercials with couples in separate bathtubs, will be lost. And how much will U.S.-UK relations be harmed by not having the attractive British woman laying on a bed talking to her American male friends about the importance of being prepared? Yes, these ads will be missed in many ways.

Pharma Guy's insight:

LaMattina, however, suggests that the animated pink intestine that Crooked Valeant uses to promote its drug for irritable bowel syndrome will still be around for many years. That’s why I included “Bubble Guts” in my gallery of mascots: http://bit.ly/pmbmascots

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

A Trip Down Viagra’s Marketing Memory Lane

A Trip Down Viagra’s Marketing Memory Lane | Pharmaguy's Insights Into Drug Industry News | Scoop.it

When Pfizer launched Viagra, in 1998, it did so with eyes wide open about the immediate impact the drug would have — on patients, of course, but also on physicians, the health media, and purveyors of late-night chuckles. What the company may not have anticipated was the longer-term influence that Viagra's wild success would wield on pharma marketing as a discipline.

 

Marketers who worked on the drug over the years, however, were not blind to the phenomenon that was brewing. “Right from the outset, it felt as if we were working on a big brand,” recalls Michael Sanzen, then VP, group copy supervisor at Cline Davis & Mann, who worked with VP, group account supervisor Ken Begasse on a broad range of HCP- and patient-communication tasks during Viagra's infancy (the two would cofound Concentric Health Experience in 2002, where they continue to work today).

 

“It was one of the first times in the pharma space where we were really ideating on what a brand needed to be based on the customer perspective, not solely on the product perspective,” Sanzen says.

 

McCann HumanCare SVP, group creative director Doug Welch, who co-led his agency's successful pitch for a big piece of Viagra business in 2004, agrees. “It felt as if we were in the middle of something big,” he says. “Would we be quite where we are today in the candor with which we discuss sensitive conditions? I honestly doubt it.”

 

While Pfizer declined an interview re­quest about Viagra's enduring legacy, a handful of marketers who worked on the campaign during its early days were happy to take a trip down memory lane. Without further ado, here are the seven ways that Pfizer's marketing of Viagra proved transformational — for Pfizer, sure, but also for the business as a whole.

 

  1. It provided the blueprint for medicalizing a supposed lifestyle condition.
  2. It created a new therapeutic category.
  3. It enabled more candid conversations with physicians.
  4. It ushered in the era of the celebrity spokesperson.
  5. It obliterated the media's reluctance to cover “embarrassing” health-related stories.
  6. It freed drug marketers to rethink their sales materials.
  7. It made a whole lot of careers.

 

More … http://bit.ly/2d8NZUe 

Pharma Guy's insight:

You might also be interested in these memories of Viagra marketing:

 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

The Mysterious World of "Mechanism of Action" Explained

The Mysterious World of "Mechanism of Action" Explained | Pharmaguy's Insights Into Drug Industry News | Scoop.it

How confident are you that the drugs you take, whether they’re over-the-counter or prescription, are totally understood by the companies who make them? Drug makers know what their products do when they enter your body, right?

You shouldn’t assume that.

Even drugs like acetaminophen have a mostly secret life once they’re inside of us. That has to do with our mysteriously complex biology and something called the “mechanism of action.”

In this episode of Signal, we talk everything from Tylenol to fen-phen to Viagra and why you should probably think hard before you take any drug at all.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Who Will Be Crowned "Miss Viagra" 2015?

Who Will Be Crowned "Miss Viagra" 2015? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Wowie zowie! Is that a roll of dimes quarters in your pocket or are you just excited to see those sexy women of every ethnic persuasion (except latina?) in Viagra ads? If there were a "Miss Viagra" beauty contest, which one would you crown Miss Viagra 2015? (I included the woman who appeared in the first ad that aired in 2014.)


Click here to vote.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Former Pfizer Exec Says Getting Docs to Prescribe Addyi Will Be a Challenge

Former Pfizer Exec Says Getting Docs to Prescribe Addyi Will Be a Challenge | Pharmaguy's Insights Into Drug Industry News | Scoop.it

While women now have access to a drug to treat a weak libido, in effect a drug to treat female sexual dysfunction, it’s really a stretch to think that this drug will have the impact both medically and commercially that the PDE-5 inhibitors like Pfizer's Viagra and Lilly's Cialis had. First of all, physicians will have to be convinced to prescribe Addyi. That’s not going to be a trivial exercise. As already stated, the drug’s effect is modest in the majority of people who might take it. But like every drug, it comes with risks, in this case dizziness, low blood pressure, fainting and sleepiness. Drinking alcohol is contraindicated as well. Many physicians will be hesitant to prescribe this drug.

Pharma Guy's insight:

I agree with the author -- John LaMattina -- about the insurance re-imbursement and efficacy issues of Addyi, but have to say that there are wonderful co-marketing possibilities! For more on that, go here: http://bit.ly/1USCJvl 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Viagra or Addyi: Which Sexy TV Ad Will Reign Supreme with Guys?

Viagra or Addyi: Which Sexy TV Ad Will Reign Supreme with Guys? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

If you are half the man you claim to be, you no doubt have NOT skipped over the new Viagra TV ads, which feature a sexy woman  telling you not to worry about your erectile dysfunction – it’s more common than you think. Just pop a Viagra pill and you’re ready to go. Meanwhile, she’ll be waiting for you for a happy ending.

Soon, however, these Pfizer full bore sex ads will have competition from Sprout Pharmaceuticals, a small drug company located in Raleigh, NC.

As many media stories proclaim, Sprout Pharmaceuticals is a drug company with a potentially very big drug – “the world’s first pill to boost women’s sex drive.” It’s called Addyi (pronounced “addie”), which, according to Sprout CEO Cindy Whitehead (shown here holding Addyi pills in her hand), is “our representation of Everywoman,” whatever that means!

The FDA will soon announce whether or not it has approved Addyi, which the company plans to market as the “little pink pill.” The agency has rejected the drug twice in the past five years because of questions about its safety and effectiveness. 

According to this media story, Whitehead assures that “Addyi is not meant to be prescribed to women looking for a little extra pizazz, or women who are bored with their husbands.” Yeah, right.

Sprout is said to have promised the FDA that it won’t run TV ads for 18 months. What will it do before then to market the drug, if approved. And what will those TV ads look like?


More...

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

New Viagra TV Ad - as Well as All Other #Pharma TV ads - Should Be Dropped, Says Former Pfizer Executive

New Viagra TV Ad - as Well as All Other #Pharma TV ads - Should Be Dropped, Says Former Pfizer Executive | Pharmaguy's Insights Into Drug Industry News | Scoop.it
While we can debate the impact of TV ads on the industry’s reputation, I find it hard to believe that the latest Viagra TV campaign is helping to “earn the trust and respect” of any of the constituents cited above. If one truly believes that the industry’s reputation is paramount, stop airing the new Viagra commercial.


*************

The new Viagra ad is not just offensive and hurts pharma's reputation, it also may be a magnet for an FDA warning letter. Read this hilarious post by PharmaGuy to find out whyOh Yeah, Baby! Show Me More!... Viagra TV Ads Like This. But Don't Let My FDA See It!

Pharma Guy's insight:


That's the opinion of John LaMattina, Former Pfizer President of R&D.


In another Forbes opinion piece titled "Pharma's Reputation Continues to Suffer -- What Can Be Done To Fix It" (find it here), LaMattina offered 4 "fixes," including "Drop TV Ads" as #4 on his list.

The other 3 fixes LaMattina put on a par with dropping TV ads are

  1. Transparency of payments to healthcare professionals, 
  2. Transparency of clinical trial data, and 
  3. Stop the illegal detailing of drugs 
  4. Drop TV Ads


Drug TV ads, says LaMattina, "may be doing more harm than good. The litany of side effects that must be discussed is numbing and probably doesn’t provide a sense of the true risk-benefit for that medication. Plus, the public views these ads to be a waste of funds that could otherwise be invested in R&D or in lessening drug costs." 


You might also be interested in reading this article:  Bad, Devalued, Distrusted & Defensive Pharma


more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Oh Yeah, Baby! Show Me More!... Viagra TV Ads Like This. But Don't Let My FDA See It!

Oh Yeah, Baby! Show Me More!... Viagra TV Ads Like This. But Don't Let My FDA See It! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Wowie zowie! Is that a roll of dimes quarters in my pocket or am I just excited to see this new Viagra DTC TV ad that features what could be a MILF? 


I pity the man who can't get an erection carousing with this woman in a beach resort or even watching her on TV lounging around the beach resort telling you that "plenty of guys" have "this issue"; i.e., getting and maintaining an erection.


Oh, Yeah! Well. I'm NOT having an issue right now!

Of course, this Viagra ad reneges on Pfizer's pledge back in 2005 to focus more on disease awareness in its DTC advertising. But (1) Pfizer withdrew that pledge (see here), and (2) this ad, IMHO, has sufficient redeeming prurient value to make us forget all about stuff like checking my blood pressure, etc. as a potential cause of ED.

But there's a fly in the ointment (not that I use the stuff). I think FDA will find problems with this ad.

Pharma Guy's insight:


This is an ad I can watch and by the time the voiceover goes through the litany of side effects, I will be so totally zoned out not to hear a word of it!


You know what's really funny yet sad? Pfizer actually did some market research to test the concept of a female ad: "The company asked 300 men to indicate whether certain TV concepts for Viagra would make them want to ask their doctors to prescribe the little blue pill. When it came to the female-focused ad, between 55% and 62% of men strongly agreed or somewhat agreed" (see here). What the hell's wrong with those 38% to 45% who disagreed? They must have been the ones with ED! 

more...
No comment yet.